CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Cash flows from operating activities:
Net loss	$ (5,432,000,000)	$ (6,752,000,000)	$ (4,688,000,000)
Depreciation and amortization	937,000,000	652,000,000	197,000,000
Stock-based compensation expense	821,000,000	987,000,000	570,000,000
Other expenses	0	0	643,000,000
Loss on convertible notes, net	0	0	441,000,000
Inventory LCNRV write-downs and losses on firm purchase commitments	107,000,000	920,000,000	95,000,000
Other non-cash activities	115,000,000	82,000,000	36,000,000
Changes in operating assets and liabilities:
Accounts receivable, net	(59,000,000)	(76,000,000)	(20,000,000)
Inventory	(1,604,000,000)	(1,657,000,000)	(369,000,000)
Other current assets	(62,000,000)	(14,000,000)	(81,000,000)
Other non-current assets	(84,000,000)	(22,000,000)	(8,000,000)
Accounts payable and accrued liabilities	105,000,000	623,000,000	461,000,000
Other current liabilities	73,000,000	104,000,000	83,000,000
Other non-current liabilities	217,000,000	101,000,000	18,000,000
Net cash used in operating activities	(4,866,000,000)	(5,052,000,000)	(2,622,000,000)
Cash flows from investing activities:
Purchases of short-term investments	(2,410,000,000)	0	0
Maturities of short-term investments	925,000,000	0	0
Capital expenditures	(1,026,000,000)	(1,369,000,000)	(1,794,000,000)
Net cash used in investing activities	(2,511,000,000)	(1,369,000,000)	(1,794,000,000)
Cash flows from financing activities:
Proceeds from share issuance upon initial public offering, net of underwriting discounts and commissions and offering costs	0	0	13,530,000,000
Proceeds from issuance of capital stock including employee stock purchase plan	61,000,000	102,000,000	2,658,000,000
Proceeds from issuance of convertible notes	3,195,000,000	0	2,500,000,000
Proceeds from issuance of long-term debt	0	0	1,226,000,000
Purchase of capped call options	(108,000,000)	0	0
Other financing activities	(18,000,000)	(3,000,000)	(86,000,000)
Net cash provided by financing activities	3,130,000,000	99,000,000	19,828,000,000
Effect of exchange rate changes on cash and cash equivalents	5,000,000	(2,000,000)	0
Net change in cash	(4,242,000,000)	(6,324,000,000)	15,412,000,000
Cash, cash equivalents, and restricted cash—Beginning of period	12,099,000,000	18,423,000,000	3,011,000,000
Cash, cash equivalents, and restricted cash—End of period	7,857,000,000	12,099,000,000	18,423,000,000
Supplemental disclosure of cash flow information:
Cash paid for interest	169,000,000	88,000,000	2,000,000
Supplemental disclosure of non-cash investing and financing activities:
Capital expenditures included in liabilities	374,000,000	364,000,000	479,000,000
Capital stock issued to settle bonuses	137,000,000	0	0
Conversion of convertible notes	0	0	2,941,000,000
Conversion of convertible preferred stock	$ 0	$ 0	$ 7,894,000,000